Universitą degli studi di Pavia
Contenuto della pagina
Seminar "Patenting Life: Politics of Innovation"
Seminar: “Patenting Life: Politics of Innovation”
Dr. Stankovic
15 dicembre 2011 ore 14:30
Aula "Adriano Buzzati Traverso" ex Dipartimento di Genetica e Microbiologia
Program
Brief summary of the talk
The recent biotechnological advances in genetic engineering, recombinant DNA, gene therapy, achieved potential for cloning animals and humans, and the isolation and manipulation of human embryonic stem cells, easily capture the imagination. The prospects for their use in biomedical applications and personalized and regenerative medicine are seemingly without boundaries, and they have created great “Patenting Life” op-ed headlines. The rapid developments in biotechnology have affected and significantly challenged many areas of law, in particular patent law. In the biomedical field, patents are extremely valuable to companies, particularly small companies. Patents provide a means of securing investment income by establishing the company’s preeminence in a particular area of (bio)technology. Research with and patentability of genes, transgenic organisms, and stem cells makes for headline news and is at the center of a myriad of ethical, religious, metaphysical, and political debates. Because the moral and legal justifications are not identical, it is possible for a legal decision to be immoral although consistent with legal precedent and procedure. Contributing to that debate and enriching the conversation, this talk addresses some of the issues surrounding patentability of inventions related to DNA, genes, stem cells, transgenic organisms and, in general, related to living matter.
Dr. Stankovic brief biography
Dr. Stankovic strives to foster improved understanding of the issues at the intersection of law, science and ethics through a variety of means, including traditional publications and presentations, as well as providing input to government and international organizations. He has made particular contributions in the areas of international intellectual property, patent and policy issues involving biotechnology or health, as well as plant molecular and space biology. He is a registered US patent attorney, teaches Patent Law at Loyola University in Chicago, and serves as a Science and Technology Advisor to the President of Macedonia Dr. Gjorge Ivanov. Dr. Stankovic has over 20 years of experience as a scientist in academic settings, including close to 5 years as a Chief Scientist at the NASA-funded Wisconsin Center for Space Automation and Robotics, University of Wisconsin-Madison, where he was the principal investigator for experiments on the Space Shuttle and the International Space Station. At the University American College Skopje he is an Associate Dean for Research at the School of Law.
Dr. Stankovic
15 dicembre 2011 ore 14:30
Aula "Adriano Buzzati Traverso" ex Dipartimento di Genetica e Microbiologia
Program
Brief summary of the talk
The recent biotechnological advances in genetic engineering, recombinant DNA, gene therapy, achieved potential for cloning animals and humans, and the isolation and manipulation of human embryonic stem cells, easily capture the imagination. The prospects for their use in biomedical applications and personalized and regenerative medicine are seemingly without boundaries, and they have created great “Patenting Life” op-ed headlines. The rapid developments in biotechnology have affected and significantly challenged many areas of law, in particular patent law. In the biomedical field, patents are extremely valuable to companies, particularly small companies. Patents provide a means of securing investment income by establishing the company’s preeminence in a particular area of (bio)technology. Research with and patentability of genes, transgenic organisms, and stem cells makes for headline news and is at the center of a myriad of ethical, religious, metaphysical, and political debates. Because the moral and legal justifications are not identical, it is possible for a legal decision to be immoral although consistent with legal precedent and procedure. Contributing to that debate and enriching the conversation, this talk addresses some of the issues surrounding patentability of inventions related to DNA, genes, stem cells, transgenic organisms and, in general, related to living matter.
Dr. Stankovic brief biography
Dr. Stankovic strives to foster improved understanding of the issues at the intersection of law, science and ethics through a variety of means, including traditional publications and presentations, as well as providing input to government and international organizations. He has made particular contributions in the areas of international intellectual property, patent and policy issues involving biotechnology or health, as well as plant molecular and space biology. He is a registered US patent attorney, teaches Patent Law at Loyola University in Chicago, and serves as a Science and Technology Advisor to the President of Macedonia Dr. Gjorge Ivanov. Dr. Stankovic has over 20 years of experience as a scientist in academic settings, including close to 5 years as a Chief Scientist at the NASA-funded Wisconsin Center for Space Automation and Robotics, University of Wisconsin-Madison, where he was the principal investigator for experiments on the Space Shuttle and the International Space Station. At the University American College Skopje he is an Associate Dean for Research at the School of Law.
